Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.44 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14638414 | 1.00 | CYP3A4 (0.45) | CYP3A4ALDH1A1KDM4EKMT2AFKBP1A | |
| SCHEMBL14637409 | 0.91 | NR1H2 (0.42) | CYP3A4ALDH1A1KDM4EKMT2ANR1H2 | |
| SCHEMBL15115348 | 0.85 | NR1H2 (0.43) | ALDH1A1KDM4EKMT2ANR1H2CYP11B1 | |
| SCHEMBL23043190 | 0.85 | CYP3A4 (0.48) | CYP3A4ALDH1A1KDM4EKMT2AFKBP1A | |
| SCHEMBL15406170 | 0.84 | FKBP1A (0.56) | CYP3A4ALDH1A1KDM4EKMT2AFKBP1A | |
| SCHEMBL5965409 | 0.84 | FKBP1A (0.56) | CYP3A4ALDH1A1KDM4EKMT2AFKBP1A | |
| SCHEMBL23042989 | 0.84 | CYP3A4 (0.47) | CYP3A4ALDH1A1KDM4EKMT2AFKBP1A | |
| SCHEMBL25955768 | 0.81 | FKBP1A (0.52) | CYP3A4ALDH1A1KDM4EKMT2AFKBP1A | |
| SCHEMBL23043376 | 0.80 | FKBP1A (0.53) | CYP3A4ALDH1A1KDM4EKMT2AFKBP1A | |
| SCHEMBL9347282 | 0.80 | FKBP1A (0.53) | CYP3A4ALDH1A1KDM4EKMT2AFKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8815909-B2 | Diaminocyclohexane compounds and uses thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-08-26 | — | — | US | disclosed |
| US-20130184284-A1 | DIAMINOCYCLOHEXANE COMPOUNDS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY | 2013-07-18 | — | — | US | disclosed |
| WO-2013012827-A1 | DIAMINOCYCLOHEXANE COMPOUNDS AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130184284-A1 | DIAMINOCYCLOHEXANE COMPOUNDS AND USES THEREOF | NPY4R, NPY2R, NPY1R | CYP3A4 1357/4885ALDH1A1 3102/4885KDM4E 1557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.